Connect with us

National

Pentagon working with gay groups on ‘Don’t Ask’ review

Defense officials seek advice, are ‘open and inclusive’

Published

on

Defense Secretary Robert Gates and Admiral Mike Mullen (Blade photo by Michael Key)

Gay organizations working to end “Don’t Ask, Don’t Tell” are enjoying an open relationship with the Pentagon working group reviewing the law as they continue to express concerns about the study deviating from its purpose.

Defense Secretary Robert Gates and Chairman of the Joint Chiefs of Staff Adm. Michael Mullen established the working group following a Feb. 2 hearing on Capitol Hill as a way to examine how to implement an end to “Don’t Ask, Don’t Tell,” should Congress repeal the law. The work is expected to be completed Dec. 1.

Alex Nicholson, executive director of Servicemembers United, said his organization has had a positive engagement with the working group since its inception.

“They brought us in — in the very beginning — to initially brief us on what they were planning to do, to answer any questions we had,” he said. “They were very open and inclusive, but not only to us. They were that way with our opposition as well.”

In one such conversation, Nicholson said the working group held a conference call to answer questions about the new regulations that were instituted last month to relax the implementation of “Don’t Ask, Don’t Tell.”

“There was a little bit of a worry, I think, in the beginning that maybe them bringing us in, being so open in answering questions, was a one-time, token gesture,” Nicholson said. “I’m pleased to say now it’s my impression that those worries, at least so far, have been unfounded. The working group has a primary point of contact for us within the Department of Defense, and that point of contact has been extremely open and extremely available.”

Nicholson said Servicemembers United first spoke with someone at the working group to express concern about the group’s mandate and noted it would set a bad precedent to poll the force on potential policy changes.

“The working group responded to that by telling us that the terms of reference have been issued, they are what they are and they don’t have control over them,” he said.

In a second round of suggestions, Nicholson said Servicemembers United passed along some ideas for the methodology the working group could institute to examine how to implement repeal. Some of the recommendations, he noted, were to advise against town hall meetings and focus groups to poll the force.

“Focus groups are a bad idea because of the phenomena of group think and posturing,” he said. “On any perceived controversial issue, you’re going to get a much a different set of answers if you ask people about it in a group rather than asking them one on one.”

Aubrey Sarvis, executive director of the Servicemembers Legal Defense Network, also said his organization’s staff have had weekly conversations and meetings with the working group.

“I think it’s been positive, ongoing,” he said. “It’s not a process that we asked for, or that we think is needed, but we’re dealing with the reality that it’s in place and we’re going to do everything that we can to make it work and have a positive contribution.”

In these conversations, Sarvis said SLDN has been recommending voices and organizations that work to end the ban on open service.

Another organization that has engaged with the working group is the Palm Center, a think tank on gays in the military at the University of California, Santa Barbara. Nathaniel Frank, a Palm Center research fellow, said he’s had a “good relationship” with the Pentagon working group.

“They’ve reached out to us consistently and they’ve been responsive to us and I’m impressed by that,” he said. “The question will be, obviously, what are the results of the study and how are they expressed. So that proof will be in the pudding.”

Frank said the working group has asked the Palm Center to make recommendations on a litany of issues, including how to identify the costs to the military of “Don’t Ask, Don’t Tell.”

“That doesn’t mean just financial costs,” he said. “It means a litany of costs to morale, recruitment, cohesion, the impact on GLB service members, and Palm is coming out with a memo that I’m finalizing now that tries to convey all of those costs.”

Frank said the working group also asked about the pitfalls of using focus groups; how to measure the views of military families; and how to empirically assess the impact of lifting the ban on unit cohesion.

Another item that Frank said he was asked about was getting the views of gay service members for the study without putting them at risk for discharge under “Don’t Ask, Don’t Tell.”

This challenge has been repeatedly discussed in hearings on Capitol Hill and among those seeking repeal. In a statement released last week, Army Secretary John McHugh said the Pentagon is “likely” to employ a third party to solicit those views.

Sarvis said his understanding is the Pentagon is considering the use of a professional consultant or pollsters who have worked with the Pentagon before on manpower issues.

“In addition, I think they’re also looking to the RAND Corp. as part of that engagement,” he said.

But the decision on how the Defense Department will obtain these views is apparently not yet final. Cynthia Smith, a Pentagon spokesperson, said in a statement to DC Agenda on April 9 that the working group is still considering the best way to incorporate gay service members into the study.

“Getting the views of gay and lesbian service members is very important to the working group,” she said. “We are still in the process of developing the proper instrument to obtain this information from gay and lesbian service members currently serving.”

Frank said he would take issue with any decision from the Pentagon to use a third party to solicit the views of gay service members because it would create a situation where service members generally would speak to one group, and gay, lesbian and bisexual service members would talk to another.

“Uniform personnel … would be consulting service members generally and then they would employ civilians or a third party only to speak to known gays and lesbians,” he said. “There’s an unfairness there in having the military speak directly to straight service members and not to gay service members.”

A better solution, Frank said, would be for the Pentagon to issue new regulations that would enable all service members to speak to the working group without fear of being discharged under “Don’t Ask, Don’t Tell.”

“The only consistent way to do it is to apply that uniformly to all people and not have separate standards, which is obviously the problem with the policy as it is,” he said.

Even with the openness between these groups and Pentagon officials, some repeal advocates say they have concerns about the working group’s direction.

Gates has repeatedly said the purpose of the group will be to examine how to implement an end to the ban should Congress repeal the law during the Senate hearing in February. But some repeal advocates say there’s a lack of clarity.

Nicholson said he has “big concerns” about the direction the group is heading, recalling testimony that Jeh Johnson, head of the Pentagon’s Office of General Counsel and co-chair of the group, gave before the House in March in which the results of the working group would inform how Congress would proceed on the issue.

“And that, I think, was very dangerous and was a new twist,” he said. “If the mission of the working group is to simply come up with an effective implementation management plan for after repeal takes effect, then there really should be no reason why Congress should need to wait for the outcome of the working group.”

Frank also acknowledged “some confusion” about whether the purpose of the working group is to study how to lift the ban or whether to lift the ban.

“I think the reason for that confusion is while the group says it’s studying how to lift the ban, given the strategic intention of the president, whether the ban is actually lifted is in the hands of the Congress,” Frank said. “So if the group comes out with a study that exaggerates the risks to cohesion, or other risks associated with lifting the ban, obviously, that will make it easier for obstructionists in Congress to try to block repeal.”

Frank called on leaders handling the group to “make it more clear that they are assessing how best to lift the ban” and note that the only reason they’re evaluating repeal is to determine how to mitigate any harm.

“It’s important to say that years and years of research across the board make clear that that impact will be negligible or non-existent, and most of us already know that,” he said.

Nicholson was particularly critical of the White House and said he thinks it’s “extremely concerning” President Obama hasn’t come out and clarified the study’s purpose. Nicholson noted that he’s been asking for clarification from the White House for several weeks now and hasn’t received a response.

“I just felt like with the working group, they’ve been very much great in communicating with us, been very receptive, I do get the impression that they’re honestly considering the suggestions we give to them,” he said. “The White House, on the other hand, it’s felt like we’ve been throwing suggestions down a black hole.”

Nicholson said he doesn’t think that White House officials are seriously considering his organization’s input and that “they ignore a lot of us for weeks at a time sometimes.”

“Unfortunately, the White House is not only not listening to or considering our suggestions and communicating with us, but they haven’t given any indication that they intend to clarify the position of the working group or curtail the expansion of its scope,” he said.

Shin Inouye, a White House spokesperson, disputed the notion that the White House wasn’t engaged with the Servicemembers United.

“The White House is actively engaged with Servicemembers United and other groups on many issues of interest to the LGBT community, including ‘Don’t Ask, Don’t Tell,'” he said in a statement.

But Sarvis said he thinks the group will stay on track with its mission as long as it adheres to its mandate and stays focused on implementing open service.

“If they move away from their mandate, if they get into polling on if or whether, or seeking the personal opinions of service members, then, yes,” he said, “I think we have a problem.”

Advertisement
FUND LGBTQ JOURNALISM
SIGN UP FOR E-BLAST

U.S. Supreme Court

Nine trans activists arrested outside Supreme Court

Gender Liberation Movement organized demonstration against Skrmetti ruling

Published

on

Protest sign outside of the U.S. Supreme Court on June 18, 2025. (Washington Blade photo by Michael Key)

On Friday afternoon, nine transgender organizers and allies were arrested on the steps of the U.S. Supreme Court for blocking the street and protesting the recent U.S. v. Skrmetti ruling.

The ruling, decided 6-3 by the conservative majority on Wednesday, upheld Tennessee’s ban on gender-affirming care for minors. The decision will allow states to pass laws restricting gender-affirming care for minors and further minimizes bodily autonomy.

The nine arrested were part of a larger group of more than 30 protesters wearing colors of the trans Pride flag— pink, blue, and white, — standing outside of the nation’s highest court. Organizers unfurled large cloths in pink, blue, and white, shared personal testimonies about how their gender-affirming care was a matter of life and death, released pink and blue smoke, and saw nine trans participants take their hormone replacement therapy.

The protest was led by the Gender Liberation Movement, an organization that “builds direct action, media, and policy interventions centering bodily autonomy, self-determination, the pursuit of fulfillment, and collectivism in the face of gender-based sociopolitical threats.” Among the nine arrested was GLM co-founder Raquel Willis.

Before being arrested, Willis spoke to multiple media outlets, explaining that this decision was an overreach of power by the Supreme Court.

“Gender-affirming care is sacred, powerful, and transformative. With this ruling in U.S. v. Skrmetti, we see just how ignorant the Supreme Court is of the experiences of trans youth and their affirming families,” said Willis. “Everyone deserves the right to holistic healthcare, and trans youth are no different. We will continue to fight for their bodily autonomy, dignity, and self-determination just like previous generations. No court, no law, no government gave us our power, and none can take it away.”

GLM co-founder Eliel Cruz also spoke to media outlets about the Skrmetti ruling, calling it “a historical moment of fascist attacks,” and encouraged the LGBTQ community to “organize and fight back.”

“As a cisgender man, I stand in solidarity with the trans community during these escalating attacks on their safety, well-being, right to exist in this world, and ability to live a future free of violence,” Cruz said. “I’m enraged at the Supreme Court’s decision to uphold a ban on gender-affirming care for youth. My heart hurts for the families and young people who this will negatively impact and harm.”

The Washington Blade reached out to Capitol Police for comment.

A spokesperson said the nine activists were arrested for violating D.C. Code §22-1307 — “Crowding, Obstructing, or Incommoding” — on First Street, N.E., after receiving three warnings.

Continue Reading

National

FDA approves new twice-yearly HIV prevention drug

Experts say success could inhibit development of HIV vaccine

Published

on

New HIV prevention drug Lenacapavir replaces oral medicines with twice-yearly injections. (Photo by fet/Bigstock)

The U.S. Food and Drug Administration (FDA) on June 18 approved a newly developed HIV/AIDS prevention drug that only needs to be taken by injection once every six months.

The new drug, lenacapavir, which is being sold under the brand name of Yeztugo by the pharmaceutical company Gilead Sciences that developed it, is being hailed by some AIDS activists as a major advancement in the years-long effort to end the HIV/AIDS epidemic in the U.S. and worldwide.

Although HIV prevention drugs, known as pre-exposure prophylaxis medication or PrEP, have been available since 2012, they initially required taking one or more daily pills. More recently, another injectable PrEP drug was developed that required being administered once every two months.

Experts familiar with the PrEP programs noted that while earlier drugs were highly effective in preventing HIV infection – most were 99 percent effective – they could not be effective if those at risk for HIV who were on the drugs did not adhere to taking their daily pills or injections every two months. Experts also point out that large numbers of people at risk for HIV, especially members of minority communities, are not on PrEP and efforts to reach out to them should be expanded.

“Today marks a monumental advance in HIV prevention,” said Carl Schmid, executive director of the D.C.-based HIV + Hepatitis Policy Institute, in a statement released on the day the FDA announced its approval of lenacapavir.

“Congratulations to the many researchers who spent 19 years to get to today’s approval, backed up by the long-term investment needed to get the drug to market,” he said.

Schmid added, “Long-acting PrEP is now not only effective for up to six months but also improves adherence and will reduce HIV infections – if people are aware of it and payers, including private insurers, cover it without cost-sharing as a preventive service.”

Schmid and others monitoring the nation’s HIV/AIDS programs have warned that proposed large scale cuts in the budget for the U.S. Centers for Disease Control and Prevention by the administration of President Donald Trump could seriously harm HIV prevention programs, including PrEP-related efforts.

“Dismantling these programs means that there will be a weakened public health infrastructure and much less HIV testing, which is needed before a person can take PrEP,” Schmid said in his statement.

“Private insurers and employers must also immediately cover Yeztugo as a required preventive service, which means that PrEP users should not face any cost-sharing or utilization management barriers,” he said.

In response to a request by the Washington Blade for comment,  a spokesperson for Gilead Sciences released a statement saying the annual list price per person using Yeztugo in the U.S. is $28,218. But the statement says the company is working to ensure that its HIV prevention medication is accessible to all who need it through broad coverage from health insurance companies and some of its own support programs.

“We’ve seen high insurance coverage for existing prevention options – for example, the vast majority of consumers have a $0 co-pay for Descovy for PrEP in the U.S. – and we are working to ensure broad coverage for lenacapavir [Yeztugo],” the statement says. It was referring to the earlier HIV prevention medication developed by Gilead Sciences, Descovy.

“Eligible insured people will get help with their copay,” the statement continues. “Gilead’s Advancing Access Copay Savings Program may reduce out-of-pocket costs to as little as zero dollars,” it says. “Then for people without insurance, lenacapavir may be available free of charge for those who are eligible, through Gilead’s Advancing Access Patient Assistance Program.”

Gilead Sciences has announced that in the two final trial tests for Yeztugo, which it describes as “the most intentionally inclusive HIV prevention clinical trial programs ever designed,” 99.9 percent of participants who received Yeztugo remained negative. Time magazine reports that among those who remained HIV negative at a rate of 100 percent were men who have sex with men. 

Time also reports that some HIV/AIDS researchers believe the success of the HIV prevention drugs like Gilead’s Yeztugo could complicate the so-far unsuccessful efforts to develop an effective HIV vaccine. 

To be able to test a potential vaccine two groups of test subjects must be used, one that receives the test vaccine and the other that receives a placebo with no drug in it. 

With highly effective HIV prevention drugs now available, it could be ethically difficult to ask a test group to take a placebo and continue to be at risk for HIV, according to some researchers. 

“This might take a bit of the wind out of the sails of vaccine research, because there is something so effective in preventing HIV infection,”  Time quoted Dr. David Ho, a professor of microbiology, immunology, and medicine at New York’s Columbia University as saying.

Continue Reading

National

Activists rally in response to Supreme Court ruling

‘We won’t bow to hatred: we outlive it’

Published

on

Hope Giselle-Godsey speaks at a rally for trans rights at the Lutheran Church of the Reformation on Wednesday, June 18. (Washington Blade photo by Michael Key)

Politicians, LGBTQ activists, and allies gathered at the Lutheran Church of the Reformation in the Capitol Hill neighborhood of Washington, D.C. on Wednesday following the ruling by the United States Supreme Court in the case of U.S. v. Skrmetti. The Supreme Court upheld a Tennessee ban on gender-affirming healthcare for transgender adolescents in a 6-3 decision.

A rally outside the U.S. Supreme Court was called for by the American Civil Liberties Union, Lambda Legal and other organizations following the high court ruling on Wednesday. However, due to a thunderstorm and flood watch, the scores of activists who were to attend the rally were directed to a Lutheran church down the street from the court. Undeterred, activists and community leaders were joined by U.S. Senators Ed Markey (D-Mass.) and Jeff Merkley (D-Ore.) for an indoor rally at the church.

“We know that freedom is not inevitable,” Markey told the crowd. “It is fought for by people who said ‘no’ in the face of health cuts, ‘no’ in the face of discrimination, ‘no’ in the face of invasive laws that ban life-saving and life-affirming healthcare and ‘no’ to this anti-justice, anti-freedom agenda.”

Also speaking at the rally was Deirdre Schifeling, chief political advocacy officer of the National ACLU.

“We believe transgender rights matter,” Schifeling stated. “Transgender kids matter and deserve love, support and the freedom to shape their own futures. I am still processing how the Supreme Court could disagree with such an obvious truth.”

“Today’s ruling shows us that unfortunately these attacks on our freedom will not end here,” Schifeling continued. “The Trump administration and extremist politicians across the country are continuing to target our right — our human right — to control our own bodies.”

“If politicians think that we are going to sit back and be defeated, that we are going to let them strip our rights and freedoms away without a fight, they’ve got another think coming,” Schifeling said. “We will never back down. We will never back down or give up. We will organize, we will mobilize and we will fight to protect trans rights in our communities, in our legislatures, in our elections, and in court rooms across the country.”

(Washington Blade photo by Michael Key)

“Today, the highest court in this land decided that the bodily autonomy of trans youth, specifically trans youth of Tennessee and states with bans harming youth across the country do not matter,” said trans advocate Hope Giselle-Godsey.

“The opponents of trans equality think that today is a victory, but history will remember it as a moment that sharpened us and not silenced us,” Giselle-Godsey continued.

“So yes, today we grieve for the people in those states where those bans exist, but we grieve in motion,” Giselle-Godsey said. “To the system that thinks that it won today, just like every other time before: you will lose again. Because we won’t bow to hatred: we outlive it. We out-organize it. We out-love it. We are still here and we are not finished yet.”

‘As we proceed, the most important pressure here is from the people,’ U.S. Sen. Jeff Merkley (D-Ore.) tells a crowd of trans rights activists at the Lutheran Church of the Reformation on Wednesday, June 18. (Washington Blade photo by Michael Key)
Continue Reading

Popular